Vitamin B12 Bicolamin Inj.

Medically Reviewed | Evidence-Based Clinical Monograph

Administration Protocol

1. Site Prep: Aseptic cleansing of injection site (deltoid or gluteal muscle).

2. Verification: Inspect solution clarity pre-administration. Discard if particulate matter is visible.

3. Delivery: Administer 1mL deep Intramuscular (IM) or Subcutaneous (SubQ) per prescribed schedule.

4. Monitoring: Assess serum B12, CBC, and MMA assays at baseline and quarterly.

Prescription Only: Restricted to licensed medical professionals. Contraindicated in patients with Leber’s optic atrophy or known hypersensitivity to cobalt/cobalamin.

Adverse Events: Anaphylactoid reactions reported in 0.02% of administration. Co-administration with chloramphenicol or proton pump inhibitors (PPIs) may attenuate therapeutic efficacy [2].

Evidence-Based Citations

[1] NIH Office of Dietary Supplements. “Vitamin B12 Fact Sheet for Health Professionals.” Clinical guidelines on neuropathy and hematopoiesis. 2025.

[2] Journal of Pharmacokinetics. “Efficacy of Parenteral Hydroxocobalamin vs Cyanocobalamin in Severe Deficiency.” Vol 42(3), pp. 112-119.